These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38243322)

  • 1. Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients.
    Eissa E; Kandil R; Dorgham D; Ghorab R; Kholoussi N
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):20. PubMed ID: 38243322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients.
    Eissa E; Morcos B; Abdelkawy RFM; Ahmed HH; Kholoussi NM
    Lupus; 2021 Jun; 30(7):1180-1187. PubMed ID: 33866896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL; Silva SC; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Front Immunol; 2024; 15():1327255. PubMed ID: 38562920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM; Farag Y; Abdelshafy M; Riad NM
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus.
    Yamada J; Peracchi OA; Terreri MT; de Moraes-Pinto MI
    Lupus; 2022 Sep; 31(10):1237-1244. PubMed ID: 35849633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    Lerkvaleekul B; Apiwattanakul N; Tangnararatchakit K; Jirapattananon N; Srisala S; Vilaiyuk S
    PLoS One; 2022; 17(2):e0263536. PubMed ID: 35130317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus.
    Ballantine LE; Ong J; Midgley A; Watson L; Flanagan BF; Beresford MW
    Pediatr Rheumatol Online J; 2014 Jan; 12():4. PubMed ID: 24433387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?
    Kanakoudi-Tsakalidou F; Farmaki E; Tzimouli V; Taparkou A; Paterakis G; Trachana M; Pratsidou-Gertsi P; Nalbanti P; Papachristou F
    Lupus; 2014 Mar; 23(3):305-12. PubMed ID: 24399813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, immunological and microbial gingival profile of juvenile systemic lupus erythematosus patients.
    Sete MRC; Carlos JC; Lira-Junior R; Boström EA; Sztajnbok FR; Figueredo CM
    Lupus; 2019 Feb; 28(2):189-198. PubMed ID: 30563424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
    Liphaus BL; Lima L; Palmeira P; Silva CA; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interleukin-2 and interferon-γ single nucleotide polymorphisms with Juvenile systemic lupus erythematosus.
    Harsini S; Ziaee V; Tahghighi F; Mahmoudi M; Rezaei A; Soltani S; Sadr M; Moradinejad MH; Aghighi Y; Rezaei N
    Allergol Immunopathol (Madr); 2016; 44(5):422-6. PubMed ID: 27255473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study.
    Giani T; Smith EM; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Pregnolato F; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Cimaz R; Beresford MW; Hedrich CM;
    Lupus; 2021 Oct; 30(12):1955-1965. PubMed ID: 34601989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients.
    Chiewchengchol D; Midgley A; Sodsai P; Deekajorndech T; Hirankarn N; Beresford MW; Edwards SW
    Clin Rheumatol; 2015 Jan; 34(1):85-91. PubMed ID: 25344776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic gingivitis management on the cytokine and anti-PPAD expressions in juvenile systemic lupus erythematosus: A six-month follow-up.
    Sete MRC; Carlos JC; Mello-Neto JM; Lira-Junior R; Brito F; Bostrom EA; Sztajnbok FR; Figueredo CM
    J Periodontal Res; 2021 Dec; 56(6):1132-1140. PubMed ID: 34510434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 promoter polymorphisms and expression in Thai children with juvenile systemic lupus erythematosus.
    Rianthavorn P; Chokedeemeeboon C; Deekajorndech T; Suphapeetiporn K
    Lupus; 2013 Jun; 22(7):721-6. PubMed ID: 23640982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.